Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line

International Immunopharmacology

Volumn 4, Issue 6, 2004, Pages 731-744

  Tejuca, M ^a,c   Diaz I ^a   Figueredo, R ^b   Roque, L ^b   Pazos, F ^a   Martinez D ^a   Iznaga Escobar, N ^b   Perez R ^b   Alvarez, C ^a   Lanio, M E ^a  

^a Universidad de La   (Cuba)

^b CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^c UNIVERSITY OF HAVANA   (Cuba)

Author keywords

Actinoporin; Cancer; Cytotoxicity; Immunotoxin; Pore forming toxin; Sea anemone cytolysin

Indexed keywords

ANTIGEN; CARBOXYLIC ACID DERIVATIVE; CYTOLYSIN; IMMUNOGLOBULIN G1; IMMUNOTOXIN; MONOCLONAL ANTIBODY IOR C5; STICHOLYSIN I; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL KILLING; CELL MEMBRANE; COLON CANCER; CONTROLLED STUDY; CROSS LINKING; CYTOLYSIS; CYTOTOXICITY; DRUG ACTIVITY; DRUG CONJUGATION; DRUG POTENCY; DRUG PURIFICATION; DRUG SCREENING; DRUG SYNTHESIS; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHILICITY; PRIORITY JOURNAL; SEA ANEMONE;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMOLYSIN PROTEINS; HEMOLYSIS; HUMANS; IMMUNOTOXINS; INDICATORS AND REAGENTS; MICE; MICE, INBRED BALB C; ORGANIC CHEMICALS; PORINS; SPLEEN;

EID: 2342574693     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.02.010     Document Type: Article

References (48)

1. Thrush G.R., Lark L.R., Clinchy B.C., Vitetta E.S. Immunotoxins: an update. Annu. Rev. Immunol. 14:1996;49-71
2. Engert A., Sausville E.A., Vitetta E.S. The emerging role of ricin A-chain immunotoxins in leukemia and lymphoma. Biosci. Rep. Top. Microbiol. Immunol. 234:1998;13-33
3. Kreitman R.J., Pastan I. Immunotoxins for targeted cancer therapy. Adv. Drug Deliv. Rev. 31:1998;53-88
4. Farah R.A., Clinchy B., Herrera L., Vitetta E.S. The development of monoclonal antibodies for the therapy of cancer. Crit. Rev. Eukaryot. Gene Expr. 8:1998;321-356
5. Kreitman R.J. Immunotoxins in cancer therapy. Biosci. Rep. Opin. Immunol. 11:1999;570-578
6. Drobniewski F.A. Immunotoxins up to the present day. Biosci. Rep. 9:1989;139-156
7. Panchal R.G. Novel therapeutic strategies to selectively kill cancer cells. Biochem. Pharmacol. 55:1998;247-252
8. Avila A.D., de Acosta M.C., Lage A. A new immunotoxin built by linking a hemolytic toxin to a monoclonal antibody specific for immature T lymphocytes. Int. J. Cancer. 42:1988;568-571
9. Avila A.D., de Acosta M.C., Lage A. A carcinoembryonic antigen-directed immunotoxin built by linking a monoclonal antibody to a hemolytic toxin. Int. J. Cancer. 43:1989;926-929
10. Pederzolli C., Belmonte G., Dalla Serra M., Macek P., Menestrina G. Biochemical and cytotoxic properties of conjugates of transferrin with equinatoxin II, a cytolysin from a sea anemone. Bioconjug. Chem. 6:1995;166-173
11. Potrich C., Viero G., Tejuca M., Anderluh G., Macek P., Menestrina G. Construction of new immunotoxins by linking equinatoxin II to monoclonal antibodies via the biotin-avidin interaction. Cytotoxic effects on human tumor cells. Acta Biol. Slov. 43:2001;47-51
12. Tejuca M., Anderluh G., Macek P., Alvarez C., Lanio M.E., et al. Antiparasite activity of sea anemone cytolysins on Giardia duodenalis and specific targeting with anti-Giardia antibodies. Int. J. Parasitol. 29:1999;489-498
13. Tejuca M., Dalla Serra M., Ferreras M., Lanio M.E., Menestrina G. The mechanism of membrane permeabilisation by sticholysin I, a cytolysin isolated from the venom of the sea anemone Stichodactyla helianthus. Biochemistry. 35:1996;14947-14957
14. Lanio M.E., Morera V., Alvarez C., Tejuca M., Gomez T., et al. Purification and characterization of two hemolysins from Stichodactyla helianthus. Toxicon. 39:2001;187-194
15. Tejuca M., Dalla Serra M., Potrich C., Alvarez C., Menestrina G. Sizing the radius of the pore formed in erythrocytes and lipid vesicles by the toxin sticholysin I from the sea anemone Stichodactyla helianthus. J. Membr. Biol. 183:2001;125-135
16. Huerta V., Morera V., Guanch Y., Chinea G., González L.J., et al. Primary structure of two cytolysin isoforms from Stichodactyla helianthus differing in their hemolytic activity. Toxicon. 39:2001;1253-1256
17. Anderluh G., Macek P. Cytolytic peptide and protein toxins from sea anemones (Anthozoa: Actinaria). Toxicon. 40:2002;111-124
18. Vázquez A.M., Tormo B.R., Velandia A., Giscombe R., Ansotegui I., et al. Characterization of the colorectal antigen ior C2. Hybridoma. 11:1992;245-256
19. Vázquez A.M., Tormo B., Velandia A., Gómez C.A., Alfonso M., Giscombe R., et al. Characterization of the Colorectal Antigen IOR C2.II. Year Immunol. 7:1993;137-145
20. Vázquez A.M., Tormo B.R., Alfonso M., Velandia A., Fernández L.E., et al. Characterization of ior C5 colorectal tumor associated antigen. Inmunología. 14:1995;28-30
21. Ramos M., Rodríguez N., Oliva J.P., Iznaga-Escobar N., Perera A., Torres L., et al. Study of in vivo examination of tumors of epithelial origin for the monoclonal antibodies ior C5, ior egf/r3 and humanized hr3, by using immunogammagraphy technique. Nucleus. 33:2003;54-63
22. Solano M.E., Perera A., Batista J.F., Candebat Z., Jacomino I., Hierro M., et al. Immunoscintigraphic diagnosis of Ovarian Cancer with Tc-99 m labeled MAb ior-C5: first clinical results. World J. Nucl. Med. 2:2003;30-36
23. Hermanson G.T. Bioconjugate techniques. 1996;Academic Press, San Diego
24. Iznaga N., Morales A., Núñez G. Micromethod for quantification of SH groups generated after reduction of monoclonal antibodies. Nucl. Med. Biol. 23:1996;641-644
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
26. Pico M.C., del Monte A., Calvo L., Torres Y., Felicó E., Otero A.J. Inmunogenicidad y especificidad antigénica de las sticholisinas I y II de la anémona de mar Stichodactyla helianthus. Rev. Biol. 14:2000;156-159
27. Bishop G.A., Hwang J. Use of a cellular ELISA for the detection of cell surface antigens. BioTechniques. 12:1992;326-330
28. Montero E., Falcon L., Morera Y., Delgado J., Amador J.F., Pérez R. CD6 molecule may be important in the pathological mechanisms of lymphocytes adhesion to human skin in psoriasis and ior t1 mAb a possible new approach to treat this disease. Autoimmunity. 29:1999;155-156
29. Bayer E.A., Wilckek M. The use of avidin-biotin complex as a tool in molecular biology. Methods Biochem. Anal. 26:1980;1-45
30. Volger C.-W. Antibody conjugate without inherent toxicity: the targeting of cobra venom factor and other biological response modifiers. Volger C.-W. Immunoconjugates: Antibody Conjugates in Radioimaging and Therapy of Cancer. 1987;170 Oxford Univ. Press, New York
31. Lambert J.M., Senter P.D., Yau-Young A., Blattler W.A., Goldmacher V.S. Purified immunotoxins that are reactive with human lymphoid cells: monoclonal antibodies conjugated to the ribosome/inactivating proteins gelonin and pokeweed antiviral proteins. J. Biol. Chem. 260:1985;12035-12041
32. Weber K., Osborn M. The reliability of molecular weight determination by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Biol. Chem. 244:1969;4406-4412
33. Giraldi T., Ferlan I., Romeo D. Antitumor activity of equinatoxin. Chem. Biol. Interact. 13:1976;199-203
34. Teng C.M., Lee L.G., Lee C.Y., Ferlan I. Platelet aggregation induced by equinatoxin. Thromb. Res. 52:1988;401-411
35. Zorec R., Tester M., Macek P., Mason W.T. Cytotoxicity of equinatoxin II from the sea anemone Actinia equina involves ion channel formation and an increase in intracellular calcium activity. J. Membr. Biol. 118:1990;243-249
36. Batista U., Macek P., Sedmak B. The cytotoxic and cytolytic activity of equinatoxin II from the sea anemone Actinia equina. Cell Biol. Int. Rep. 14:1990;1013-1024
37. Anderluh G., Menestrina G. Pore-forming proteins from sea anemones and the construction of immunotoxins for selective killing of harmful cells. Fingerman M., Nagabhushanam R. Bio-organic compounds: chemistry and medical applications. Recent Advances in Marine Biotechnology. vol. 6:2001;131-148 Science, Enfield, USA
38. Anderluh G., Barlic A., Podlesek Z., Macek P., Pungercar J., et al. Cysteine scanning mutagenesis of an eucaryotic pore-forming toxin from sea anemone: topology in lipid membranes. Eur. J. Biochem. 263:1999;128-136
39. Anderluh G., Barlic A., Potrich C., Macek P., Menestrina G. Lysine 77 is a key residue in aggregation of equinatoxin II, a pore-forming toxin from sea anemone Actinia equina. J. Membr. Biol. 173:2000;47-55
40. Varanda A., Finkelstein A. Ion and non electrolyte permeability properties of channels formed in planar lipid bilayer membranes by the cytolytic toxin from the sea anemone, Stoichactis helianthus. J. Membr. Biol. 55:1980;203-211
41. Iznaga N., Morales A., Núñez G. A Computer Program for Quantification of SH Groups Generated after Reduction of Monoclonal Antibodies. Nucl. Med. Biol. 23:1996;635-639
42. De Los Rios V., Mancheno J.M., Martinez del Pozo A., Alfonso C., Rivas G., et al. II. Sticholysin, a cytolysin from the sea anemone Stichodactyla helianthus, is a monomer-tetramer associating protein. FEBS lett. 455:1999;27-30
43. Willingham M.C., Haigler H.T., FitzGerald D.L., Gallo M.G., Rutherford A.V., Pastan I.H. The morphologic pathway of binding and internalization of epidermal growth factor in cultured cells. Studies on A431, KB, and 3T3 cell, using multiple methods of labelling. Exp. Cell Res. 146:1983;163-175
44. Youle R.J., Neville D.M.J. Kinetics of protein synthesis inactivation by ricin-anti-Thy monoclonal antibody hybrids. role of the ricin B subunit demonstrated by reconstitution. J. Biol. Chem. 257:1982;1598-1601
45. Engert A., Burrows F., Jung W.E., Tazzari P.L., Stein H., et al. Evaluation of ricin A chain-containing immunotoxins directed against CD30 as potential reagents for the treatment of Hodgkin's disease. Cancer Res. 50:1989;84-88
46. Press O.W., Vitetta E.S., Farr A.G., Hansen J.A., Martin P.J. Evaluation of ricin A-chain immunotoxins directed against human T cells. Cell Immunol. 102:1986;10-20
47. May R.D., Finkelman F., Vitetta E.S. Evaluation of ricin A Chain containing immunotoxins directed against different epitopes on the delta chain of sIgD on murine B cells. J. Immunol. 144:1990;3637-3642
48. Roque L. Obtention of recombinant antibodies recognizing colon-specific antigens to be used in diagnosis and therapeutics. Rev. Cuba. Quím. XIII:2001;56